Pure Global

Effectiveness and Safety of Directional Deep Brain Stimulation for Parkinson's Disease - Trial NCT05992701

Access comprehensive clinical trial information for NCT05992701 through Pure Global AI's free database. This phase not specified trial is sponsored by Beijing Pins Medical Co., Ltd and is currently Recruiting. The study focuses on Parkinson's Disease. Target enrollment is 28 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
Device Trial
NCT05992701
Recruiting
Device Trial
device
Trial Details
ClinicalTrials.gov โ€ข NCT05992701
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Effectiveness and Safety of Directional Deep Brain Stimulation for Parkinson's Disease

Study Focus

Parkinson's Disease

Directional deep brain stimualtion

Interventional

device

Sponsor & Location

Beijing Pins Medical Co., Ltd

Beijing,Beijing,Chengdu,Kunming,Nanjing,Shanghai,Shenzhen,Tianjin,Wuhan, China

Timeline & Enrollment

N/A

Jul 28, 2021

Jun 30, 2024

28 participants

Primary Outcome

Therapeutic Window

Summary

The purpose of this study is to demonstrate the safety and effectiveness of the PINS Deep
 Brain Stimulation (DBS) system, including the G107R/G107 IPG, L305/L306 directional leads,
 E204 extensions and related system components.

ICD-10 Classifications

Parkinson disease
Parkinsonism in diseases classified elsewhere
Dementia in Parkinson disease
Secondary parkinsonism
Postencephalitic parkinsonism

Data Source

ClinicalTrials.gov

NCT05992701

Device Trial